Level One Partners Supports Watermill’s Proposal for Ziopharm Oncology
Press release content from Business Wire. The AP news staff was not involved in its creation.
CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–Nov 13, 2020–
Level One Partners, LLC, (“Level One Partners”) along with all of its related entities, will vote 100% of its approximately 10.68 million shares of Ziopharm Oncology, Inc. (NASDAQ: ZIOP) (“Ziopharm” or the “Company”) in support of the WaterMill Asset Management Corp. proposal for a reconstituted Board of Directors and significant changes to the governance of the Company. Level One Partners’ 10.68 million shares equal approximately 4.98% of the Company’s outstanding shares.
Level One Partners stated: “We believe WaterMill’s proposed new board members possess the business acumen and experience necessary to help lead the Company in achieving its strategic goals. With new board member leadership, we believe the Company can begin to maximize shareholder value and unlock the potential of its extraordinary science.”
Level One Partners, LLC, is a private investment firm located in Charlottesville, Virginia.
View source version on businesswire.com:https://www.businesswire.com/news/home/20201113005160/en/
CONTACT: Robert D. Hardie
Level One Partners
434-326-4717
KEYWORD: UNITED STATES NORTH AMERICA VIRGINIA
INDUSTRY KEYWORD: PROFESSIONAL SERVICES FINANCE
SOURCE: Level One Partners, LLC
Copyright Business Wire 2020.
PUB: 11/13/2020 09:00 AM/DISC: 11/13/2020 09:01 AM
http://www.businesswire.com/news/home/20201113005160/en
